Cipla receives USFDA approval for generic HIV drug
Cipla has received approval to market Efavirenz tablets, from the US health regulator. The company stated that, it has received final approval from the United States...
Tag : Cipla
Cipla Outlook for the Week (June 18, 2018 – June 22, 2018)
EquityPandit’s Outlook for Cipla for the week (June 18, 2018 – June 22, 2018) : CIPLA: CIPLA closed the week on positive note gaining around 9.30%....
Cipla receives USFDA approval for generic Isuprel injection
Cipla has received green signal for Isoproterenol Hydrochloride injection, from the US health regulator. It is used for treating cardiac problems, in the American market. The...
Cipla Outlook for the Week (June 11, 2018 – June 15, 2018)
EquityPandit’s Outlook for Cipla for the week (June 11, 2018 – June 15, 2018) : CIPLA: CIPLA closed the week on positive note gaining around 6.70%....
Cipla Outlook for the Week (June 04, 2018 – June 08, 2018)
EquityPandit’s Outlook for Cipla for the week (June 04, 2018 – June 08, 2018) : CIPLA: CIPLA closed the week on negative note losing around 2.30%....
Cipla Outlook for the Week (May 28, 2018 – June 01, 2018)
EquityPandit’s Outlook for Cipla for the week (May 28, 2018 – June 01, 2018) : CIPLA: CIPLA closed the week on positive note gaining around 0.70%....
Cipla Q4 net profit at Rs.153 crore
Cipla has reported a net profit of Rs.153.25 crore, for the quarter ended March 31,2018. The company in the same quarter last year, had reported...
Cipla Outlook for the Week (May 21, 2018 – May 25, 2018)
EquityPandit’s Outlook for Cipla for the week (May 21, 2018 – May 25, 2018) : CIPLA: CIPLA closed the week on negative note losing around 7.00%....
Stempeutics ties up with Cipla for its stem cell drug
Stempeutics has inked an out-licensing deal with Cipla, for its stem cell therapy product Stempeucel. It is suggested for treating critical limb ischemia. In a...
Cipla Outlook for the Week (May 14, 2018 – May 18, 2018)
EquityPandit’s Outlook for Cipla for the week (May 14, 2018 – May 18, 2018) : CIPLA: CIPLA closed the week on negative note losing around 3.90%....